Batterjee has been in his current role since 2014. Batterjee Pharma supplies the PIF-owned Badael with nicotine replacements, with the goal of getting a million smokers to quit. In January 2024, the company localized the manufacturing of six products from the U.S. to Saudi Arabia. In February 2024, it launched two patented products developed in Saudi universities. Batterjee is also the cofounder of AUMET, a health-tech platform.